Marzia Khan

Feature Writer

M.Sc. in Nanotechnology and Regenerative Medicine, B.Sc. in Biomedical Sciences

Marzia Khan is a lover of scientific research and innovation. She immerses herself in literature and novel therapeutics which she does through her position on the Royal Free Ethical Review Board. Marzia has a MSc in Nanotechnology and Regenerative Medicine as well as a BSc in Biomedical Sciences. She is currently working in the NHS and is engaging in a scientific innovation program.

Articles from Marzia

Systems Biology in Drug Development

Learn about the role of systems biology in drug development in the AZoLifeSciences article.

27 Nov 2023

The Hidden Complexity of Tumor Heterogeneity

Tumor heterogeneity can cause non-uniform distribution of cancer cell subpopulations that are genetically distinct across and within tumor sites, as well as variations in their molecular signature.

16 Oct 2023

The Mechanisms of DNA Damage and Repair

In this article, AZoLifeSciences explores how DNA damage can occur and the mechanisms underpinning DNA repair.

31 Aug 2023

What Is a Representative Cell Culture?

A representative cell culture can be described as a sample of cells that is used by researchers to represent a larger population of cells.

11 Jul 2023

Studying the Metabolic Pathways Between Tissues

In this article, AZoLifeSciences discusses how metabolic pathways between tissues are studied.

13 Jun 2023

Importance of Cell Heterogeneity for Genomics Research

Cell heterogeneity is the result of genetic variation and the biological difference between cells of different types as well as the same type or population and can be due to various factors.

1 Jun 2023

Folding Matters: Unraveling the Impact of Protein Folding on Biological Processes

Protein folding is integral for normal physiology, such as development and aging, which can be compromised with dysfunctional protein folding that can result in disease pathologies such as neurodegeneration and cancer.

31 May 2023

Combining Proteomics and Genomics to Eliminate Disease

Combining both genomics and proteomics is a significant benefit for many reasons, as this comprehensive approach can cover all disease associations within the body and reveal many biological targets for drug development.

16 May 2023

Insight into Next-Generation Protein Therapeutics

Next-generation protein therapeutics have become popular amongst researchers, especially after the emergence and development of novel COVID-19 vaccines, including mRNA vaccines, that thrust this concept into the spotlight at a global scale.

16 May 2023